Expert Opinion on Drug Metabolism & Toxicology

Expert Opinion on Drug Metabolism & Toxicology is published by Taylor and Francis Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Computational Drug Discovery Methods, together about 41.5% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)

Aims and scopeJournal metrics Editorial board Expert Opinion on Drug Metabolism & Toxicology [ISSN 1742-5255]; [e-ISSN 1744-7607] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Drug Metabolism & Toxicology addresses the needs of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals. The Editors welcome: Reviews covering: metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. Please note that the journal does not publish case reports, case series, or animal studies. Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Reach an international clinical and medical audience alongside other key opinion leaders in your field by publishing with Expert Opinion on Drug Metabolism & Toxicology, part of the Expert Collection brand. Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services. For any pre-submission enquiries, please contact the Commissioning Editor. Read full aims and scope

From the journal's Aims & Scope

Research area (LetPub): Biochemistry & Molecular Biology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

4.67LetPub · 2026-09-13

CiteScore 2026-06

5.6LetPub · 2026-09-13

SJR 2026-06

0.99LetPub · 2026-09-13

SNIP 2026-06

1.36LetPub · 2026-09-13

h-index

72LetPub · 2026-09-13

h-index

120OpenAlex · 2026-10-01

i10-index

1,662OpenAlex · 2026-10-01

2-year mean citedness

4.77OpenAlex · 2026-10-01

Self-citation rate

2.2%LetPub · 2026-09-13

Share of gold OA articles

4.69%LetPub · 2026-09-13

Volume

Articles per year

78LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

4–8 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly easyLetPub · 2026-09-13

Peer review

Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Taylor and Francis Ltd.

Country or region

ENGLAND

Language

English

Frequency

Bimonthly

Founded

2005

ISSN

1742-5255

Electronic ISSN

1744-7607

Latest issue on the website

Volume 22, Issue 7 (2026)

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗Publisher website
• Special issues ↗Publisher website